Pantoprazole Stada

Pantoprazole, the active ingredient in Pantoprazole Stada, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and ulcers in adults.

GNH USA supplies Pantoprazole Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole Stada is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): Improves symptoms and promotes healing of the oesophageal lining. - Erosive oesophagitis: Facilitates healing of erosive damage in the oesophagus. - Peptic ulcer disease: Supports ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: Controls excessive gastric acid production associated with this rare endocrine disorder.

Pantoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: Mild to moderate intensity. - Diarrhea: Loose stools without blood. - Nausea: Feeling of stomach discomfort. - Abdominal pain: Cramp‑like discomfort in the abdomen. - Flatulence: Excessive gas formation. - Constipation: Reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: Severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: Inflammation of the kidney interstitium causing renal impairment. - Severe hypersensitivity reactions: Rash, itching, swelling, or anaphylaxis. - Osteoporosis‑related fractures: Increased risk of hip, wrist or vertebral fractures with long‑term use. - Low magnesium levels (hypomagnesemia): May cause muscle cramps, seizures or cardiac arrhythmia.

When prescribing Pantoprazole Stada, clinicians should consider several safety aspects: - Assess renal function: Adjust dose in patients with severe renal impairment. - Monitor for infections: Watch for signs of Clostridioides difficile‑related diarrhea. - Evaluate bone health: Use the lowest effective dose for the shortest duration to limit fracture risk. - Review concomitant medications: Assess for potential drug‑drug interactions that may affect absorption or efficacy. - Store below 25°C: Keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole Stada can interact with several medicines, requiring careful management:

Major Interactions (Avoid): - Ketoconazole oral: Reduced absorption due to increased gastric pH. - Atorvastatin: Increased plasma concentration, raising risk of muscle toxicity. - Warfarin: Potential enhancement of anticoagulant effect, requiring INR monitoring.

Moderate Interaction (​​​​    ​  ​  ​  ​  ​ ​    ).